HomeFGEN • NASDAQ
add
FibroGen Inc
Previous close
$0.39
Day range
$0.38 - $0.40
Year range
$0.18 - $2.93
Market cap
39.41M USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 46.33M | 15.45% |
Operating expense | 17.55M | -31.36% |
Net income | -17.08M | 73.14% |
Net profit margin | -36.87 | 76.74% |
Earnings per share | 0.01 | 102.81% |
EBITDA | 2.52M | 105.19% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 131.00M | -47.88% |
Total assets | 264.42M | -42.57% |
Total liabilities | 466.12M | -19.02% |
Total equity | -201.70M | — |
Shares outstanding | 100.77M | — |
Price to book | -0.16 | — |
Return on assets | 1.59% | — |
Return on capital | -6.56% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -17.08M | 73.14% |
Cash from operations | -8.38M | 90.09% |
Cash from investing | 755.00K | -98.61% |
Cash from financing | -127.00K | -477.27% |
Net change in cash | -9.71M | 69.34% |
Free cash flow | 10.04M | 117.97% |
About
Founded
Jan 1, 1993
Headquarters
Website
Employees
486